DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 123 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $261,000 | -95.2% | 66,091 | -87.3% | 0.02% | -92.7% |
| Q3 2016 | $5,474,000 | +29.2% | 521,875 | +79.6% | 0.20% | -7.2% |
| Q2 2016 | $4,236,000 | +0.1% | 290,505 | +32.0% | 0.22% | +4.2% |
| Q1 2016 | $4,233,000 | +46.0% | 220,000 | +83.3% | 0.21% | +33.3% |
| Q4 2015 | $2,899,000 | -12.5% | 120,000 | -11.1% | 0.16% | +16.9% |
| Q3 2015 | $3,312,000 | +102.0% | 134,954 | +92.8% | 0.14% | +126.7% |
| Q2 2015 | $1,640,000 | – | 70,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |